3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Breast Neoplasms
5
Ovarian Neoplasms
2
Colorectal Neoplasms
2
Tuberous Sclerosis
1
Pyloric Stenosis, Hypertrophic
1
Prostatic Neoplasms
1
Pediatric Solid Tumor
1
Pancreatic Neoplasms
1
Neoplasms, Unknown Primary
1
Neoplasms
1
Lymphangioleiomyomatosis
1
Histiocytosis, Non-Langerhans-Cell
1
Histiocytosis, Langerhans-Cell
1
HER2-positive Breast Cancer
1
Early Detection of Cancer
1
Colorectal Neoplasms, Hereditary Nonpolyposis
1
Castleman Disease
1
Breast Screening
1
Breast Neoplasms, Male
1
Brain Neoplasms
1
Anatomic Stage II Breast Cancer AJCC v8
1
Interventions
Magnetic Resonance Spectroscopy
22
Temozolomide
18
Specimen Handling
13
X-Rays
9
Biopsy
9
Radiotherapy
8
Radiation
8
trametinib
6
Phantoms, Imaging
6
Nuclear Medicine Department, Hospital
6
Bevacizumab
6
larotrectinib
4
erdafitinib
4
dabrafenib
4
ulixertinib
3
palbociclib
3
abemaciclib
3
Surgical Procedures, Operative
3
Nivolumab
3
Cyclophosphamide
3
vorasidenib
2
tipifarnib
2
tazemetostat
2
selpercatinib
2
olaparib
2
mirdametinib
2
lutetium Lu 177 dotatate
2
ivosidenib
2
fluorodopa F 18
2
fludarabine
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Glioma
×
Genetic Testing
×
90 days
×
Clear all
No trials found.